|
BR112015007674A2
|
|
improved process for purifying milk lactoferrin and milk products
|
|
US2015173396A1
|
|
Casein products and c02 reversible acidification methods used for their production
|
|
AU2013204850A1
|
|
Improved process for purifying milk proteins and products thereof
|
|
AU2011213773A1
|
|
Process for the Preparation of a Mineral Whey Product
|
|
NZ606186A
|
|
Use of lactoferrin to treat proteinuria
|
|
WO2011113100A1
|
|
Method of treating a bone disorder
|
|
WO2011060489A1
|
|
Transgenic non-human animals
|
|
CA2818467A1
|
|
Recombinant microorganisms
|
|
US2011262422A1
|
|
Orally administrable dosage forms comprising angiogenin and uses thereof
|
|
AU2008288677A1
|
|
Compositions comprising phospholipids
|
|
US2008293159A1
|
|
Validation Process
|
|
CA2649982A1
|
|
Formulation comprising whey protein and hydrolysates for improving muscle recovery
|
|
CN101282763A
|
|
Milk derived composition and use to enhance muscle mass or muscle strength
|
|
CA2621739A1
|
|
Composition of whey growth factor extract for reducing muscle inflammation
|
|
AU2006289665A1
|
|
Milk derived composition and use to enhance muscle mass or muscle strength
|
|
AU2006252322A1
|
|
Process for producing a mineral whey product
|
|
CA2612182A1
|
|
Process for producing a mineral whey product
|
|
CA2607082A1
|
|
Immunoglobulin fraction and process therefor
|
|
NZ563098A
|
|
Immunoglobulin fraction and process therefor
|
|
WO2006066332A1
|
|
Method of manufacture of a modified milk powder suitable as a rennet casein extender or replacer
|
